Details for Patent: 4,957,922

Summary for Patent: 4,957,922

Title:	Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3- carboxylic acid
Abstract:	An aqueous infusion solution containing 0.015 to 0.5 g of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-car box ylic acid per 100 ml of aqueous solution and an amount of at least one physiologically tolerated acid which suffices to dissolve the active compound.
Inventor(s):	Lammens; Robert F. (Leverkusen, DE), Mahler; Hans F. (Colonge, DE), Serno; Peter (Colonge, DE)
Assignee:	Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:	07/329,922
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 4,957,922

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,957,922

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	3537761	Oct 24, 1985

International Family Members for US Patent 4,957,922

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	244085
Austria	59003
Australia	571796
Australia	6432786
Canada	1282006
China	1015871
China	87100728